Get the Stockscreener App
6.295
7.38%
-0.615
Aclarion Inc stock is traded at $6.295, with a volume of 51,412.
It is down -7.38% in the last 24 hours and down -14.67% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$6.91
Open:
$6.9
24h Volume:
51,412
Relative Volume:
0.40
Market Cap:
$4.20M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.6925
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
+2.24%
1M Performance:
-14.67%
6M Performance:
-5.25%
1Y Performance:
+40.84%
1-Day Range:
$6.05
$7.15
1-Week Range:
$6.05
$8.09
52-Week Range:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
6.26 | 4.66M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
242.31 | 39.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.20 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
47.87 | 9.66B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.50 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.27 | 6.77B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Stock (ACON) Latest News
Can Aclarion Inc. Equity Warrant stock maintain growth trajectory2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Will Aclarion Inc. stock deliver better than expected guidance2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Aclarion’s Nociscan featured in special pain issue of spine journal By Investing.com - Investing.com Nigeria
Is Aclarion Inc. (IT20) stock vulnerable to rate hikes2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
How Aclarion Inc. (IT20) stock gains from tech spendingMarket Performance Recap & Weekly Stock Performance Updates - Newser
Why Aclarion Inc. (IT20) stock stays resilientJuly 2025 Decliners & Target Return Focused Picks - Newser
How sustainable is Aclarion Inc. Equity Warrant stock dividend payout2025 Market Trends & Detailed Earnings Play Alerts - Newser
Aclarion, Inc. Stock (ACON) Opinions on Nociscan Technology Publication - Quiver Quantitative
Aclarion stock rises after feature in special pain issue of spine journal - Investing.com India
Aclarion’s Nociscan featured in special pain issue of spine journal - Investing.com
Aclarion announces publication of Nociscan article in pain issue of IJSS - TipRanks
Aclarion's Nociscan Featured in International Journal of Spine Surgery's Special Pain Issue, Highlighting Advances in Chronic Low Back Pain Diagnosis - Quiver Quantitative
Aclarion (Nasdaq: ACON) Nociscan case study guides targeted spine surgery - Stock Titan
Can Aclarion Inc. (IT20) stock sustain double digit ROEJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Is Aclarion Inc. (IT20) stock suitable for passive index fundsJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Will Aclarion Inc. (IT20) stock sustain uptrend momentumQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Will Aclarion Inc. stock remain a Wall Street favoriteIPO Watch & Target Return Focused Stock Picks - Newser
Aug Intraday: Will QRAFT AI Enhanced U.S. Large Cap stock return to pre crash levelsJuly 2025 PostEarnings & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Will Aclarion Inc. Equity Warrant stock reach Wall Street targets2025 Momentum Check & Real-Time Chart Pattern Alerts - Newser
How Aclarion Inc. stock performs in high volatility marketsTrade Exit Report & Advanced Swing Trade Entry Plans - Newser
Will Aclarion Inc. (IT20) stock outperform energy sector in 20252025 Volatility Report & AI Powered Market Trend Analysis - Newser
Aclarion, Inc. Appoints Jason Brosniak as Commercial Director for the Eastern U.S - marketscreener.com
Aclarion, Inc. (ACON) 15.7% in Intraday Trading: Appointment of Commercial Director Drives Interest - Stocks Telegraph
Aclarion appoints Jason Brosniak as commercial director, Eastern U.S. - TipRanks
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - Yahoo Finance
Is Aclarion's Debt-Free Position The Backbone Of Its Next Phase Of Expansion? - RTTNews
2 innovative micro-cap stocks for 2026 - MSN
2 innovative micro-cap stocks for 2026 | 2025-12-01 | Investing News - Stockhouse
Is Aclarion Inc Equity Warrant a good long term investmentEarnings Forecast Updates & Affordable Growth Investments - earlytimes.in
Momentum Shift: Why Aclarion Inc. stock appeals to dividend seekersQuarterly Risk Review & Precise Buy Zone Identification - BỘ NỘI VỤ
Can Aclarion Inc. stock hit record highs againInflation Watch & Fast Moving Market Watchlists - BỘ NỘI VỤ
What margin trends mean for Aclarion Inc. stockMarket Activity Summary & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ
Aclarion loss widens, but balance sheet remains strong - BizWest
Is Aclarion Inc a good long term investmentLarge Cap Stability Picks & Access Our Free Weekly Investment Letter - earlytimes.in
Critical Review: Aclarion (ACON) vs. The Competition - Defense World
Aclarion Inc. (ACON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Aclarion Inc. (IT20) stock stays on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com
Is Aclarion Inc. Equity Warrant stock trading near support levels2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Positive Outlook on Aclarion, Inc. Driven by Revenue Growth and Strategic Investments - TipRanks
Ascendiant Capital Maintains Aclarion (ACON) Buy Recommendation - Nasdaq
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Aclarion (ACON) Sees Price Target Boost by Ascendiant Capital | - GuruFocus
How interest rate cuts could boost Aclarion Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
How Aclarion Inc. stock compares to industry benchmarksLong Setup & Detailed Earnings Play Alerts - newser.com
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.59%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):